Skip to content

Company information lookup

NOVOGEN LIMITED (NRT)

Oncology drug research and development.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
NRT 0.145 16% 0.140 0.145 0.135 0.145 0.135 596,290

NOVOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code NRT
Securities
Official Listing Date 1 September, 1994
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.novogen.com
Registered Office Address Level 1, 16-20 Edgeworth David Ave, HORNSBY, NSW, AUSTRALIA, 2077
Head Office Telephone (02) 9476 0344
Head Office Fax (02) 9476 0388
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Dr Graham Kelly (Chairman, CEO)
Mr Steven R Coffey (Non Exec. Director)
Prof. Peter Gunning (Non Exec. Director)
Mr John P O'Connor (Non Exec. Director)
Mr Iain Ross (Non Exec. Director)
Mr David Gryska (External Advisor)
Company Secretary Mr Lionel Mateo
Principal Activities Oncology drug research and development.

NOVOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
22/10/2014   Appointment of TLM for ASX Bookbuild and Webinar details 3 PDF
22/10/2014 asterix Studies confirm potential of Trilexium for childhood cancers 3 PDF
16/10/2014   Novogen announces capital raising via ASX Bookbuild facility 4 PDF
10/10/2014   Notice of Annual General Meeting/Proxy Form 27 PDF
03/10/2014   Annual Report to shareholders 81 PDF
01/10/2014 asterix FDA provides guidance for the development of Cantrixil 2 PDF
29/09/2014   ABC interview of Dr Kelly about the potential of Trilexium 2 PDF
29/08/2014 asterix Full Year Statutory Accounts 64 PDF
19/08/2014   Change of Director's Interest Notice 3 PDF
13/08/2014   Results of Meeting 4 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Oct 2014 0.145 16% 0.145 0.135 596,290
23 Oct 2014 0.125 4.17% 0.125 0.125 65,000
22 Oct 2014 0.120 0% 0.130 0.120 169,036
21 Oct 2014 0.120 -4% 0.120 0.120 168,940
17 Oct 2014 0.125 0% 0.130 0.120 210,799

* Volume of shares shown represents only those shares traded on ASX.

NOVOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NRT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NRT

Warrants & Structured Products

No warrants & Structured Products are available over the security NRT